|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q98238255
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010903.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q98238255
|
|
024
|
|
|
‡a
0000-0001-6951-1448
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q98238255
|
|
100
|
0 |
|
‡a
Jolanda M Smit
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Jolanda M Smit
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's A fusion-loop antibody enhances the infectious properties of immature flavivirus particles
|
|
670
|
|
|
‡a
Author's A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells
|
|
670
|
|
|
‡a
Author's A small molecule fusion inhibitor of dengue virus
|
|
670
|
|
|
‡a
Author's A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
|
|
670
|
|
|
‡a
Author's Adaptation of Alpha viruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin
|
|
670
|
|
|
‡a
Author's Altered immune response of immature dendritic cells following dengue virus infection in the presence of specific antibodies
|
|
670
|
|
|
‡a
Author's An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro
|
|
670
|
|
|
‡a
Author's Antibodies against immature virions are not a discriminating factor for dengue disease severity
|
|
670
|
|
|
‡a
Author's Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2
|
|
670
|
|
|
‡a
Author's Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses
|
|
670
|
|
|
‡a
Author's Arthropod-borne flaviviruses and RNA interference: seeking new approaches for antiviral therapy
|
|
670
|
|
|
‡a
Author's Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress
|
|
670
|
|
|
‡a
Author's Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking
|
|
670
|
|
|
‡a
Author's Chikungunya virus fusion properties elucidated by single-particle and bulk approaches
|
|
670
|
|
|
‡a
Author's Chikungunya virus requires an intact microtubule network for efficient viral genome delivery
|
|
670
|
|
|
‡a
Author's Complex interaction between dengue virus replication and expression of miRNA-133a
|
|
670
|
|
|
‡a
Author's Dengue: a growing risk to travellers to tropical and sub-tropical regions
|
|
670
|
|
|
‡a
Author's Dengue tropism for macrophages and dendritic cells: the host cell effect
|
|
670
|
|
|
‡a
Author's Dengue virus life cycle: viral and host factors modulating infectivity
|
|
670
|
|
|
‡a
Author's Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
|
|
670
|
|
|
‡a
Author's Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease
|
|
670
|
|
|
‡a
Author's Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells
|
|
670
|
|
|
‡a
Author's Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells
|
|
670
|
|
|
‡a
Author's Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion
|
|
670
|
|
|
‡a
Author's Flavivirus cell entry and membrane fusion
|
|
670
|
|
|
‡a
Author's Functional importance of dengue virus maturation: infectious properties of immature virions
|
|
670
|
|
|
‡a
Author's How antibodies alter the cell entry pathway of dengue virus particles in macrophages
|
|
670
|
|
|
‡a
Author's Immature Dengue Virus: A Veiled Pathogen?
|
|
670
|
|
|
‡a
Author's Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN.
|
|
670
|
|
|
‡a
Author's Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells
|
|
670
|
|
|
‡a
Author's Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans
|
|
670
|
|
|
‡a
Author's Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells
|
|
670
|
|
|
‡a
Author's Neuroinvasive flavivirus infections
|
|
670
|
|
|
‡a
Author's Partial maturation: an immune-evasion strategy of dengue virus?
|
|
670
|
|
|
‡a
Author's Reversible Acid-Induced Inactivation of the Membrane Fusion Protein of Semliki Forest Virus
|
|
670
|
|
|
‡a
Author's Role of antibodies in controlling dengue virus infection
|
|
670
|
|
|
‡a
Author's Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers
|
|
670
|
|
|
‡a
Author's Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus
|
|
670
|
|
|
‡a
Author's The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
|
|
670
|
|
|
‡a
Author's Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression
|
|
909
|
|
|
‡a
(orcid) 0000000169511448
‡9
1
|
|
919
|
|
|
‡a
dengueagrowingrisktotravellerstotropicalandsubtropicalregions
‡A
Dengue: a growing risk to travellers to tropical and sub-tropical regions
‡9
1
|
|
919
|
|
|
‡a
fusionloopantibodyenhancestheinfectiouspropertiesofimmatureflavivirusparticles
‡A
A fusion-loop antibody enhances the infectious properties of immature flavivirus particles
‡9
1
|
|
919
|
|
|
‡a
singlemutationinthee2glycoproteinimportantforneurovirulenceinfluencesbindingofsindbisvirustoneuroblastomacells
‡A
A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells
‡9
1
|
|
919
|
|
|
‡a
smallmoleculefusioninhibitorofdenguevirus
‡A
A small molecule fusion inhibitor of dengue virus
‡9
1
|
|
919
|
|
|
‡a
therapeuticantibodyagainstwestnilevirusneutralizesinfectionbyblockingfusionwithinendosomes
‡A
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
‡9
1
|
|
919
|
|
|
‡a
adaptationof Alpha virusestoheparansulfateinteractionofsindbisandsemlikiforestviruseswithliposomescontaininglipidconjugatedheparin
‡A
Adaptation of Alpha viruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin
‡9
1
|
|
919
|
|
|
‡a
alteredimmuneresponseofimmaturedendriticcellsfollowingdenguevirusinfectioninthepresenceofspecificantibodies
‡A
Altered immune response of immature dendritic cells following dengue virus infection in the presence of specific antibodies
‡9
1
|
|
919
|
|
|
‡a
analogueoftheantibioticteicoplaninpreventsflavivirusentryinvitro
‡A
An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro
‡9
1
|
|
919
|
|
|
‡a
antibodiesagainstimmaturevirionsarenotadiscriminatingfactorfordenguediseaseseverity
‡A
Antibodies against immature virions are not a discriminating factor for dengue disease severity
‡9
1
|
|
919
|
|
|
‡a
antibodiesagainsttheenvelopeglycoproteinpromoteinfectivityofimmaturedenguevirusserotype2
‡A
Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2
‡9
1
|
|
919
|
|
|
‡a
antibodydependentenhancementofdenguevirusinfectioninprimaryhumanmacrophagesbalancinghigherfusionagainstantiviralresponses
‡A
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses
‡9
1
|
|
919
|
|
|
‡a
arthropodborneflavivirusesandrnainterferenceseekingnewapproachesforantiviraltherapy
‡A
Arthropod-borne flaviviruses and RNA interference: seeking new approaches for antiviral therapy
‡9
1
|
|
919
|
|
|
‡a
broadlyneutralizing Alpha virusantibodiesbindanepitopeone2andinhibitentryandegress
‡A
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress
‡9
1
|
|
919
|
|
|
‡a
characterizationoftheearlyeventsindengueviruscellentrybybiochemicalassaysandsinglevirustracking
‡A
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking
‡9
1
|
|
919
|
|
|
‡a
chikungunyavirusfusionpropertieselucidatedbysingleparticleandbulkapproaches
‡A
Chikungunya virus fusion properties elucidated by single-particle and bulk approaches
‡9
1
|
|
919
|
|
|
‡a
chikungunyavirusrequiresanintactmicrotubulenetworkforefficientviralgenomedelivery
‡A
Chikungunya virus requires an intact microtubule network for efficient viral genome delivery
‡9
1
|
|
919
|
|
|
‡a
complexinteractionbetweendenguevirusreplicationandexpressionofmirna133a
‡A
Complex interaction between dengue virus replication and expression of miRNA-133a
‡9
1
|
|
919
|
|
|
‡a
denguetropismformacrophagesanddendriticcellsthehostcelleffect
‡A
Dengue tropism for macrophages and dendritic cells: the host cell effect
‡9
1
|
|
919
|
|
|
‡a
dengueviruslifecycleviralandhostfactorsmodulatinginfectivity
‡A
Dengue virus life cycle: viral and host factors modulating infectivity
‡9
1
|
|
919
|
|
|
‡a
developmentofahighlyprotectivecombinationmonoclonalantibodytherapyagainstchikungunyavirus
‡A
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
‡9
1
|
|
919
|
|
|
‡a
differentialexpressionoftolllikereceptorsindendriticcellsofpatientswithdengueduringearlyandlateacutephasesofthedisease
‡A
Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease
‡9
1
|
|
919
|
|
|
‡a
dissectingthecellentrypathwayofdenguevirusbysingleparticletrackinginlivingcells
‡A
Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells
‡9
1
|
|
919
|
|
|
‡a
dynamicsofchikungunyaviruscellentryunraveledbysinglevirustrackinginlivingcells
‡A
Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells
‡9
1
|
|
919
|
|
|
‡a
earlyeventsinchikungunyavirusinfectionfromviruscellbindingtomembranefusion
‡A
Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion
‡9
1
|
|
919
|
|
|
‡a
flaviviruscellentryandmembranefusion
‡A
Flavivirus cell entry and membrane fusion
‡9
1
|
|
919
|
|
|
‡a
functionalimportanceofdenguevirusmaturationinfectiouspropertiesofimmaturevirions
‡A
Functional importance of dengue virus maturation: infectious properties of immature virions
‡9
1
|
|
919
|
|
|
‡a
howantibodiesalterthecellentrypathwayofdenguevirusparticlesinmacrophages
‡A
How antibodies alter the cell entry pathway of dengue virus particles in macrophages
‡9
1
|
|
919
|
|
|
‡a
immaturedenguevirusaveiledpathogen
‡A
Immature Dengue Virus: A Veiled Pathogen?
‡9
1
|
|
919
|
|
|
‡a
immaturedenguevirusisinfectiousinhumanimmaturedendriticcellsviainteractionwiththereceptormolecule600sign
‡A
Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN.
‡9
1
|
|
919
|
|
|
‡a
mechanismandroleofmcp1upregulationuponchikungunyavirusinfectioninhumanperipheralbloodmononuclearcells
‡A
Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells
‡9
1
|
|
919
|
|
|
‡a
molecularmechanismsinvolvedinantibodydependentenhancementofdenguevirusinfectioninhumans
‡A
Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans
‡9
1
|
|
919
|
|
|
‡a
moxidectinandivermectininhibitsarscov2replicationinveroe6cellsbutnotinhumanprimaryairwayepitheliumcells
‡A
Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells
‡9
1
|
|
919
|
|
|
‡a
neuroinvasiveflavivirusinfections
‡A
Neuroinvasive flavivirus infections
‡9
1
|
|
919
|
|
|
‡a
partialmaturationanimmuneevasionstrategyofdenguevirus
‡A
Partial maturation: an immune-evasion strategy of dengue virus?
‡9
1
|
|
919
|
|
|
‡a
reversibleacidinducedinactivationofthemembranefusionproteinofsemlikiforestvirus
‡A
Reversible Acid-Induced Inactivation of the Membrane Fusion Protein of Semliki Forest Virus
‡9
1
|
|
919
|
|
|
‡a
roleofantibodiesincontrollingdenguevirusinfection
‡A
Role of antibodies in controlling dengue virus infection
‡9
1
|
|
919
|
|
|
‡a
structureofacidicphdenguevirusshowingthefusogenicglycoproteintrimers
‡A
Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers
‡9
1
|
|
919
|
|
|
‡a
suppressionofchikungunyavirusreplicationanddifferentialinnateresponsesofhumanperipheralbloodmononuclearcellsduringcoinfectionwithdenguevirus
‡A
Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus
‡9
1
|
|
919
|
|
|
‡a
complexityofadenguevaccineareviewofthehumanantibodyresponse
‡A
The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
‡9
1
|
|
919
|
|
|
‡a
tomatidinereduceschikungunyavirusprogenyreleasebycontrollingviralproteinexpression
‡A
Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000389685052
|
|
996
|
|
|
‡2
NTA|067807151
|
|
996
|
|
|
‡2
NTA|230184405
|
|
996
|
|
|
‡2
NTA|114130086
|
|
996
|
|
|
‡2
ISNI|0000000387794482
|
|
996
|
|
|
‡2
ISNI|0000000388336475
|
|
996
|
|
|
‡2
ISNI|0000000053427519
|
|
996
|
|
|
‡2
NTA|313999805
|
|
996
|
|
|
‡2
ISNI|0000000393841871
|
|
996
|
|
|
‡2
NTA|173746314
|
|
996
|
|
|
‡2
LC|n 93042699
|
|
996
|
|
|
‡2
ISNI|0000000390035751
|
|
996
|
|
|
‡2
BNF|15079685
|
|
996
|
|
|
‡2
ISNI|0000000389600194
|
|
996
|
|
|
‡2
DNB|1164265601
|
|
996
|
|
|
‡2
ISNI|0000000390397330
|
|
996
|
|
|
‡2
ISNI|0000000391726319
|
|
996
|
|
|
‡2
ISNI|0000000396845317
|
|
996
|
|
|
‡2
NTA|130522155
|
|
996
|
|
|
‡2
NTA|149220219
|
|
996
|
|
|
‡2
ISNI|0000000395486324
|
|
996
|
|
|
‡2
NTA|34468797X
|
|
996
|
|
|
‡2
NTA|073267104
|
|
996
|
|
|
‡2
PTBNP|132656
|
|
996
|
|
|
‡2
NTA|140299645
|
|
996
|
|
|
‡2
NTA|326916547
|
|
996
|
|
|
‡2
ISNI|0000000396377285
|
|
996
|
|
|
‡2
NTA|340817844
|
|
996
|
|
|
‡2
LC|no 94021732
|
|
996
|
|
|
‡2
BIBSYS|90580284
|
|
996
|
|
|
‡2
NTA|067815111
|
|
996
|
|
|
‡2
LC|n 86040693
|
|
996
|
|
|
‡2
NTA|071773517
|
|
996
|
|
|
‡2
NTA|073295353
|
|
996
|
|
|
‡2
NTA|183844025
|
|
996
|
|
|
‡2
NTA|401445372
|
|
996
|
|
|
‡2
NTA|130877204
|
|
996
|
|
|
‡2
ISNI|0000000023370144
|
|
996
|
|
|
‡2
SUDOC|228965985
|
|
996
|
|
|
‡2
NTA|158586271
|
|
996
|
|
|
‡2
NTA|06973142X
|
|
996
|
|
|
‡2
NTA|303022957
|
|
996
|
|
|
‡2
NTA|311664709
|
|
996
|
|
|
‡2
ISNI|0000000389561180
|
|
996
|
|
|
‡2
ISNI|0000000031357812
|
|
996
|
|
|
‡2
NTA|074080563
|
|
996
|
|
|
‡2
ISNI|0000000390228238
|
|
996
|
|
|
‡2
ISNI|0000000391252993
|
|
996
|
|
|
‡2
NTA|071773525
|
|
996
|
|
|
‡2
NTA|156250551
|
|
996
|
|
|
‡2
LC|no2004093377
|
|
996
|
|
|
‡2
NTA|070468036
|
|
996
|
|
|
‡2
LC|no 99053893
|
|
996
|
|
|
‡2
PLWABN|9810558176805606
|
|
996
|
|
|
‡2
NTA|154090271
|
|
996
|
|
|
‡2
ISNI|0000000393705351
|
|
996
|
|
|
‡2
NTA|158586182
|
|
996
|
|
|
‡2
NTA|419403787
|
|
996
|
|
|
‡2
ISNI|0000000391468890
|
|
996
|
|
|
‡2
ISNI|0000000390038530
|
|
996
|
|
|
‡2
NTA|069769354
|
|
996
|
|
|
‡2
NTA|241724163
|
|
996
|
|
|
‡2
ISNI|0000000391181048
|
|
996
|
|
|
‡2
ISNI|0000000394423313
|
|
996
|
|
|
‡2
NTA|074409689
|
|
996
|
|
|
‡2
BIBSYS|14011316
|
|
996
|
|
|
‡2
ISNI|0000000392013679
|
|
996
|
|
|
‡2
NTA|298542730
|
|
996
|
|
|
‡2
NTA|146139402
|
|
996
|
|
|
‡2
LC|n 82044427
|
|
996
|
|
|
‡2
ISNI|0000000031179999
|
|
996
|
|
|
‡2
NTA|374326649
|
|
996
|
|
|
‡2
NUKAT|nx2022852724
|
|
996
|
|
|
‡2
LC|n 79117359
|
|
996
|
|
|
‡2
NTA|068409877
|
|
996
|
|
|
‡2
LC|n 80161773
|
|
996
|
|
|
‡2
NTA|074017675
|
|
996
|
|
|
‡2
ISNI|0000000390212615
|
|
996
|
|
|
‡2
LC|n 79074995
|
|
996
|
|
|
‡2
ISNI|0000000392670150
|
|
996
|
|
|
‡2
ISNI|0000000396195967
|
|
996
|
|
|
‡2
NTA|149094396
|
|
996
|
|
|
‡2
ISNI|0000000459423219
|
|
996
|
|
|
‡2
LC|no2003038488
|
|
996
|
|
|
‡2
NTA|241674921
|
|
996
|
|
|
‡2
ISNI|0000000392151959
|
|
996
|
|
|
‡2
ISNI|0000000392624699
|
|
996
|
|
|
‡2
NTA|296198803
|
|
996
|
|
|
‡2
ISNI|0000000392966058
|
|
996
|
|
|
‡2
NTA|073793760
|
|
996
|
|
|
‡2
NTA|067806058
|
|
996
|
|
|
‡2
NTA|163102996
|
|
996
|
|
|
‡2
NTA|31432173X
|
|
996
|
|
|
‡2
NTA|156264153
|
|
996
|
|
|
‡2
ISNI|0000000084730844
|
|
996
|
|
|
‡2
NTA|072656190
|
|
996
|
|
|
‡2
BIBSYS|90832641
|
|
996
|
|
|
‡2
ISNI|0000000395806287
|
|
996
|
|
|
‡2
NTA|072909560
|
|
996
|
|
|
‡2
NTA|074401580
|
|
996
|
|
|
‡2
ISNI|0000000388117942
|
|
996
|
|
|
‡2
ISNI|0000000395783521
|
|
996
|
|
|
‡2
NTA|325853010
|
|
996
|
|
|
‡2
NTA|413982106
|
|
996
|
|
|
‡2
NTA|156109875
|
|
996
|
|
|
‡2
RERO|A003838689
|
|
996
|
|
|
‡2
NTA|32155163X
|
|
996
|
|
|
‡2
NTA|241724139
|
|
996
|
|
|
‡2
NTA|18968688X
|
|
996
|
|
|
‡2
NTA|27345448X
|
|
996
|
|
|
‡2
NTA|172481694
|
|
996
|
|
|
‡2
NTA|331202751
|
|
996
|
|
|
‡2
NTA|072910291
|
|
996
|
|
|
‡2
NTA|161922309
|
|
996
|
|
|
‡2
LC|n 98052367
|
|
996
|
|
|
‡2
NTA|108728145
|
|
996
|
|
|
‡2
BAV|495_80511
|
|
996
|
|
|
‡2
ISNI|0000000389278473
|
|
996
|
|
|
‡2
ISNI|0000000394677612
|
|
996
|
|
|
‡2
NTA|171522435
|
|
996
|
|
|
‡2
NTA|071773495
|
|
996
|
|
|
‡2
ISNI|0000000395108542
|
|
996
|
|
|
‡2
NTA|292774915
|
|
996
|
|
|
‡2
JPG|500354603
|
|
996
|
|
|
‡2
NTA|109488164
|
|
996
|
|
|
‡2
NTA|070288690
|
|
996
|
|
|
‡2
ISNI|0000000395464037
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Smit, J.M.
‡q
(Jolanda Mariske),
‡2
NTA|239386817
‡3
title: (0.74, 'molecularmechanismsofdenguevirusinfectioncelltropismantibodydependentenhancementandcytokines', 'molecularmechanismsinvolvedinantibodydependentenhancementofdenguevirusinfectioninhumans')
|
